Vertex Pharmaceuticals Stock News

The 'Undercovered' Dozen highlights 12 lesser-covered stocks, showcasing diverse investment opportunities and sparking community discussion on their potential. Xinyu Ru sees Argan, Inc. as undervalued with strong growth in gas and renewable energy projects, trading at 21x 1-year forward earnings. AES Corporation's sell-off creates a buying opportunity according to Zenzizenzike Investments due t...

What you do in the present makes a huge difference in how successful you'll be in the future. This is true in a wide array of activities -- including investing.

Vertex Pharmaceuticals reported strong Q3 earnings, yet the stock has pulled back, presenting a buying opportunity. The company's robust pipeline, particularly Suzetrigine for acute pain and CASGEVY gene therapy, positions Vertex for significant growth. Vertex's financial health, with no traditional debt and substantial cash reserves, supports its aggressive push into new therapeutic areas and ...

The top five biotech stocks today have several commonalities. Among them are strong ratings.

Got $500? 1 Biotech Stock to Buy and Hold Forever

Biotech Vertex Pharmaceuticals (VRTX) has been struggling on the charts over the past few weeks, putting a dent in its now 10% year-to-date gain. The stock's 5.6% post-earnings pop earlier this month has already been erased, and VRTX is now trading at its lowest level since June.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Stifel 2024 Healthcare Conference November 19, 2024 8:00 AM ET Company Participants Stuart Arbuckle - EVP, COO Conference Call Participants Paul Matteis - Stifel Paul Matteis Great, good morning. It's my pleasure to be moderating this chat with Stuart Arbuckle, COO of Vertex Pharmaceuticals.

3 Growth Stocks You Can Buy Right Now Without Any Hesitation